Citation Impact

60 standout
Sub-graph 1 of 18

Citing Papers

Breast cancer detection using deep learning: Datasets, methods, and challenges ahead
2022 Standout
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
15 intermediate papers

Works of Massimo Menga being referenced

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
2012
Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP.
2009

Author Peers

Author PFM PRM Surgery RNMI Neurology Last Decade Papers Cites
Massimo Menga 237 86 4 121 105 13 294
Somayyeh Rahimi 2 2 20 469
Edward J. Downes 1 6 388
Surab Vadachkoria 9 19 74 15 739
Mark F. Saxby 173 71 14 6 14 295
Ahmed Y. Shanab 7 4 19 34 12 9 340

All Works

Loading papers...

Rankless by CCL
2026